May, 31st 2019
Dr. Nina Bauer recently presented on the new ekko(TM) platform and several applications being developed with our customers
Stanley Kowalski, CEO of FloDesign Sonics, has taken to calling 2015 "the year of the product" for his Wilbraham company, when he will focus on getting his device aimed at upending the manufacturing process for biologic drugs out to as many pharmaceutical firms as possible.
On Thursday, FloDesign Sonics, based in Wilbraham, Mass., announced a $10 million Series A led by Bright Capital. The new round of funding also included investments from Ventry Industries of Springfield, as well a James Waters, the founder of Waters Corp., and Jonathan Fleming of Oxford Biosciences.
FloDesign Sonics, a Wilbraham firm working on a way to use sound to separate particles from a liquid in drug development, has gotten a $10 million investment led by Bright Capital.